Evidence map›Paper›PMID 33425917›Full record

ReviewFrontiers in cell and developmental biology2020

Mitochondrial Membrane Intracellular Communication in Healthy and Diseased Myocardium.

Vishnu K Kumar, Atreju Lackey, Jonathan Snyder, Sunil Karhadkar, Ajay D Rao, Antonio DiCarlo, Priscila Y Sato

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vishnu K KumarDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, United States.
Atreju LackeyDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, United States.
Jonathan SnyderDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, United States.
Sunil KarhadkarDepartment of Surgery, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.
Ajay D RaoSection of Endocrinology, Diabetes and Metabolism, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.
Antonio DiCarloDepartment of Surgery, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.
Priscila Y SatoDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, United States.
Drexel University · USTemple University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research efforts in the twenty-first century have been paramount to the discovery and development of novel pharmacological treatments in a variety of diseases resulting in improved life expectancy. Yet, cardiac disease remains a leading cause of morbidity and mortality worldwide. Over time, there has been an expansion in conditions such as atrial fibrillation (AF) and heart failure (HF). Although past research has elucidated specific pathways that participate in the development of distinct cardiac pathologies, the exact mechanisms of action leading to disease remain to be fully characterized. Protein turnover and cellular bioenergetics are integral components of cardiac diseases, highlighting the importance of mitochondria and endoplasmic reticulum (ER) in driving cellular homeostasis. More specifically, the interactions between mitochondria and ER are crucial to calcium signaling, apoptosis induction, autophagy, and lipid biosynthesis. Here, we summarize mitochondrial and ER functions and physical interactions in healthy physiological states. We then transition to perturbations that occur in response to pathophysiological challenges and how this alters mitochondrial-ER and other intracellular organelle interactions. Finally, we discuss lifestyle interventions and innovative therapeutic targets that may be used to restore beneficial mitochondrial and ER interactions, thereby improving cardiac function.

Indexed as

endoplasmic reticulum stressheartmembrane communication mechanismmitochondriamitochondria-ER communication

Identifiers

PMID33425917
PMCPMC7786191
OpenAlexW3115645982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.